177 related articles for article (PubMed ID: 37596991)
1. TAM receptors in phagocytosis: Beyond the mere internalization of particles.
Burstyn-Cohen T; Fresia R
Immunol Rev; 2023 Oct; 319(1):7-26. PubMed ID: 37596991
[TBL] [Abstract][Full Text] [Related]
2. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
Shafit-Zagardo B; Gruber RC; DuBois JC
Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
[TBL] [Abstract][Full Text] [Related]
3. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
4. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
[TBL] [Abstract][Full Text] [Related]
5. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A
Dis Markers; 2020; 2020():1614627. PubMed ID: 32051695
[TBL] [Abstract][Full Text] [Related]
6. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury.
Brosius Lutz A; Chung WS; Sloan SA; Carson GA; Zhou L; Lovelett E; Posada S; Zuchero JB; Barres BA
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8072-E8080. PubMed ID: 28874532
[TBL] [Abstract][Full Text] [Related]
7. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
8. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.
Ghosh Roy S
Int Rev Cell Mol Biol; 2020; 357():81-122. PubMed ID: 33234246
[TBL] [Abstract][Full Text] [Related]
9. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
10. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.
Tondo G; Perani D; Comi C
Dis Markers; 2019; 2019():2387614. PubMed ID: 31636733
[TBL] [Abstract][Full Text] [Related]
11. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Peeters MJW; Rahbech A; Thor Straten P
Cancer Immunol Immunother; 2020 Feb; 69(2):237-244. PubMed ID: 31664482
[TBL] [Abstract][Full Text] [Related]
12. Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.
Rothlin CV; Leighton JA; Ghosh S
Inflamm Bowel Dis; 2014 Aug; 20(8):1472-80. PubMed ID: 24846720
[TBL] [Abstract][Full Text] [Related]
13. Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily.
Perez F; Iribarren ML; Olexen CM; Ruera CN; Errasti AE; Guzman L; Garbi L; Carrera Silva EA; Chirdo FG
Clin Immunol; 2024 Jun; 263():110202. PubMed ID: 38575045
[TBL] [Abstract][Full Text] [Related]
14. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
[TBL] [Abstract][Full Text] [Related]
16. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment.
Zhou L; Matsushima GK
Int Rev Cell Mol Biol; 2021; 361():165-210. PubMed ID: 34074493
[TBL] [Abstract][Full Text] [Related]
17. Biology of the TAM receptors.
Lemke G
Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a009076. PubMed ID: 24186067
[TBL] [Abstract][Full Text] [Related]
18. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
Cai B; Kasikara C
Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
[TBL] [Abstract][Full Text] [Related]
19. TAM receptors in cardiovascular disease.
McShane L; Tabas I; Lemke G; Kurowska-Stolarska M; Maffia P
Cardiovasc Res; 2019 Jul; 115(8):1286-1295. PubMed ID: 30980657
[TBL] [Abstract][Full Text] [Related]
20. TAM receptor signaling in development.
Burstyn-Cohen T
Int J Dev Biol; 2017; 61(3-4-5):215-224. PubMed ID: 28621419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]